Rehaler
New drug free migraine treatment developed by the Danish company BalancAir. Learn more
Launch date
Employees
Company register number 32562205
Kongens Lyngby Capital Region of Denmark (HQ)
Financials
Estimates*
EUR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|---|---|---|
EBITDA | - | - | - | (<1m) | (<1m) | (<1m) | (<1m) |
Profit | (<1m) | (<1m) | (<1m) | (<1m) | <1m | (<1m) | (<1m) |
Date | Investors | Amount | Round |
---|---|---|---|
€1.5m | Grant | ||
N/A | Early VC | ||
Total Funding | €1.5m |
Recent News about Rehaler
EditMore about Rehaler
EditDeveloper of drug-free migraine treatment designed to prevent and reduce pain during a migraine attack. The company provides an individualized treatment plan along with guided migraine treatment, enabling patients to stop their migraine attacks before the pain starts and easily reduce the pain during the attack.
Keywords: Healthcare Devices, Services, Supplies, Drugs Free Treatment, Migraine Care, Migraine Cure, Migraine Therapy, Migraine Treatment, Migraine Treatment Product, Reduce Pain.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.